Intravenous Versus Perineural Ondansetron for Laparoscopic Sleeve Gastrectomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorTanta University
About this trial
This prospective randomized non-inferiority study will be conducted to compare the analgesic anti-emetic effects of intravenous ondansetron versus perineural ondansetron in patients undergoing laparoscopic sleeve gastrectomy.
Eligibility criteria
Qualifiers
Patients of either sex
American Society Anesthesiologists physical (ASA) status II-III
age between 18-65 years old
Body mass index (BMI) >35 kg/m2 with comorbidity or > 40 kg/m2 -- undergoing laparoscopic sleeve gastrectomy with intraoperative surgeon performed laparoscopic paragastric autonomic neural blockade..
Disqualifiers
Allergy to experimental drugs.
Known to have long QT, previous history of postoperative nausea and vomiting
Abuse of alcohol, analgesia, or sedative antidepressant drugs
Chronic pain disorders
Trial design
Treatments tested in this trial
- Perineural ondansetron
- Intravenous ondansetron
Treatment groups
482 Participants
are divided into 2 treatment groupsLocations
1Tanta University Hospitals31527, TantaGharbia Governorate, Egypt
Sponsors and collaborators
Tanta University
Lead sponsor
Source ClinicalTrials.gov